anemia%20-%20iron-deficiency
ANEMIA - IRON-DEFICIENCY
Anemia is a condition wherein the blood has low levels of red blood cells (RBC), hemoglobin (oxygen-carrying pigment in whole blood) and/or hematocrit (intact RBC in blood) making it insufficient to address the physiologic needs of the body.
Iron-deficiency anemia is the anemia that resulted from inadequate iron supplementation or excessive blood loss.
It is the most common nutritional disorder worldwide and accounts for more than half of anemia cases.
It is prevalent among preschool children and pregnant women.

Definition

  • A condition wherein the blood has low levels of red blood cells (RBC), hemoglobin (oxygen-carrying pigment in whole blood) or hematocrit (intact RBC in the blood) making it insufficient to address the physiologic needs of the body
  • Based on WHO, anemia is defined as having the following hemoglobin concentrations1:
    • Men (≥15 years old): <13 g/dL
    • Women (non-pregnant, ≥15 years old): <12 g/dL
    • Women (pregnant): <11 g/dL in the 1st and 3rd trimesters, declines by 0.5 g/dL in the 2nd trimester
    • Children (12-14 years old): <12 g/dL
    • Children (5-11 years old): <11.5 g/dL
    • Children (6 months - 4 years old): <11 g/dL

1Values for the definition of anemia may vary between countries. Please refer to available guidelines from local health authorities.

Etiology

Causes of Anemia

  • Normocytic anemia when RBC morphology is unremarkable 
    • Blood loss - most common cause
    • Decreased RBC production due to low RBC production or destruction of precursors of RBC within the bone marrow, eg chronic disease
    • Increased RBC destruction, eg hemolysis
  • Macrocytic anemia wherein the RBC is larger than the nucleus of a small lymphocyte on a peripheral smear due to:
    • Megaloblastic causes: Folate and vitamin B12 deficiency, HIV infection, rare inborn errors of metabolism, myelodysplastic syndrome or congenital dyserythropoietic anemia
    • Nonmegaloblastic causes: Marked reticulocytosis, aplastic anemia, abnormal nucleic acid metabolism of erythroid precursors interfering with nucleic acid synthesis, abnormal RBC maturation, other causes such as Down syndrome, alcohol abuse, liver disease and hypothyroidism
  • Microcytic anemia when RBCs appear smaller due to the following pathologic processes:
    • Reduced iron availability/iron-deficiency anemia
    • Acquired disorders of heme synthesis, eg thalassemia 
    • Reduced globin production
    • Rare congenital disorders including sideroblastic anemias, porphyria, and defects of iron absorption transport, utilization and recycling
    • Inflammation or chronic disease
    • Lead poisoning

Signs and Symptoms

  • Primary symptoms include: Dyspnea (exertional or at rest), fatigue, palpitations, headache, faintness or lightheadedness, tinnitus, anorexia, gastrointestinal (GI) disturbances, loss of libido
  • Symptoms of severe anemia include: Lethargy, confusion, tachycardia, retinal hemorrhage that may lead to life-threatening complications such as congestive heart failure, angina, arrhythmia and/or myocardial infarction
  • Symptoms can be due to decreased oxygen delivery to tissues and in patients with acute and marked bleeding, the added insult of hypovolemia
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
03 Apr 2019
The sodium‐glucose‐cotransporter‐2 inhibitor empagliflozin yields beneficial effects on weight anthropometric parameters and body composition—including weight, body mass index, waist and hip circumference, and total body fat—that are greater than those achieved with metformin in overweight and obese women with polycystic ovary syndrome (PCOS), a study has shown.
Stephen Padilla, 03 Apr 2019
The risk of miscarriage is lowest at age 27 years but increases with older age and by up to four times after three consecutive previous miscarriages, according to a Norway study. This risk is also associated with earlier pregnancy complications, including stillbirth, preterm delivery and gestational diabetes.
Pearl Toh, 08 May 2019
Continuous chemotherapy confers better survival and quality of life than intermittent scheduling in patients with advanced breast cancer, according to the Stop&Go study presented at EBCC 2019.